|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Playing The High-Stakes Biotech Game
10/19/2005 5:08:58 PM
Shares of biotechnology companies have declined, after the much anticipated American Society of Clinical Oncologists meeting in early June in New Orleans. This sector has been on a roll ever since Genentech (NYSE: DNA) vaulted 45% on May 19, 2003 following positive news from Phase III trials of Avastin in colorectal cancer patients. Is the recent correction a good time to fish or cut-bait?
|
|
|
|
|
|
|
• Celltech Group PLC
|
|
• Celltech R&D, Inc.
|
|
• Millennium Pharmaceuticals, Inc. (South San Francisco, California)
|
|
• Atrix Laboratories, Inc.
|
|
• UCB Pharma
|
|
• Celltech Pharmaceuticals, Inc.
|
|
• QLT Inc.
|
|
• Elan Corporation PLC
|
|
• Cephalon, Inc.
|
|
• UCB Research Inc.
|
|
• Chiron Corporation (now Novartis Vaccines & Diagnostics)
|
|
• Chiron Corporation (now Novartis Vaccines & Diagnostics)
|
|
• Genta Incorporated
|
|
• Roche
|
|
• Amgen San Francisco
|
|
• Roche
|
|
• ImClone Systems
|
|
• Gilead Sciences, Inc.
|
|
• Genentech
|
|
• Biogen Idec, Inc. (Massachusetts)
|
|
• Biogen Idec, Inc. (North Carolina)
|
|
• OSI Pharmaceuticals, Inc.
|
|
• Millennium: The Takeda Oncology Company
|
|
• Amgen
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|